Epidemiology, diagnosis, and treatment patterns of prostate cancer in Algeria
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
This project collects medical and treatment information to see how prostate cancer is diagnosed and managed in Algerian men with confirmed disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 19 Years and up |
| Sex | Male |
| Sponsor | Société Algérienne de Formation et Recherche en Oncologie Academic / other |
| Locations | 24 sites (Adrar, Algeria and 23 other locations) |
| Trial ID | NCT07484971 on ClinicalTrials.gov |
What this trial studies
This is a descriptive, cross-sectional observational study enrolling up to 500 patients with histologically and/or biologically confirmed prostate cancer who are followed at participating centers in Algeria. Data are collected from medical records and a structured ~30-minute patient interview and entered into a standardized electronic case report form to ensure completeness. The study records sociodemographic details, medical history, clinical and biological disease features, diagnostic tests performed, and therapeutic strategies used. All data are anonymized and used solely for research purposes to characterize current practice patterns and outcomes.
Who should consider this trial
Good fit: Men aged 19 years or older with histologically and/or biologically confirmed prostate cancer who are followed at the participating oncology or radiotherapy departments and can provide written informed consent.
Not a fit: Patients with non-carcinoma histological types, secondary tumors, or those currently enrolled in interventional trials are excluded and would not benefit from joining this observational project.
Why it matters
Potential benefit: If successful, the study could clarify current diagnostic and treatment patterns and highlight gaps to improve care and health planning for prostate cancer in Algeria.
How similar studies have performed: Similar observational registries and cross-sectional studies in other countries have successfully described care patterns and outcomes and helped guide local improvements, so this approach is established rather than novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 19 years and older. * Diagnosis of prostate cancer confirmed histologically and/or biologically. * Patients followed in the participating oncology departments. * Written informed consent obtained. Non Inclusion Criteria: * Histological types other than carcinoma * Secondary tumors * Participation in an interventional study
Where this trial is running
Adrar, Algeria and 23 other locations
- CAC Adrar - Oncology Department — Adrar, Algeria, Algeria (Not_yet_recruiting)
- CAC Adrar - Radiotherapy Department — Adrar, Algeria, Algeria (Not_yet_recruiting)
- CAC BLIDA - Oncology Department — Algiers, Algeria, Algeria (Recruiting)
- Centre Pierre et Marie Curie - Oncology Department — Algiers, Algeria, Algeria (Recruiting)
- Centre Pierre et Marie Curie - Radiology Department — Algiers, Algeria, Algeria (Recruiting)
- CHU Bab El Oued — Algiers, Algeria, Algeria (Recruiting)
- CHU Béni Messous - Oncology Departement — Algiers, Algeria, Algeria (Recruiting)
- EPH ROUIBA - Oncology Department — Algiers, Algeria, Algeria (Recruiting)
- CAC Annaba - Oncology Departement — Annaba, Algeria, Algeria (Recruiting)
- CAC Annaba - Radiotherapy Department — Annaba, Algeria, Algeria (Recruiting)
- CAC Annaba - Urology Departement — Annaba, Algeria, Algeria (Recruiting)
- CAC Bida - Radiotherapy Department — Blida, Algeria, Algeria (Recruiting)
- CAC BLIDA - Urology Department — Blida, Algeria, Algeria (Recruiting)
- CHU Constantine - Oncology Departement — Constantine, Algeria, Algeria (Recruiting)
- EH Constantine - Oncology Departement — Constantine, Algeria, Algeria (Recruiting)
- EPH Mostaghanem - Oncology Department — Mostaganem, Algeria, Algeria (Recruiting)
- CAC ORAN - Oncology Department — Oran, Algeria, Algeria (Recruiting)
- CAC ORAN - Radiotherapy Department — Oran, Algeria, Algeria (Recruiting)
- EHU ORAN - Oncology Department — Oran, Algeria, Algeria (Not_yet_recruiting)
- EHU ORAN - Urology Department — Oran, Algeria, Algeria (Recruiting)
- CAC Sétif - Oncology Departement — Sétif, Algeria, Algeria (Recruiting)
- CAC Sétif - Radiotherapy Department — Sétif, Algeria, Algeria (Recruiting)
- EPH Sidi Ghilès - Oncology Department — Tipasa, Algeria, Algeria (Recruiting)
- CAC Draa Ben Khedda - Radiotherapy Departement — Tizi Ouzou, Algeria, Algeria (Recruiting)
Study contacts
- Study coordinator: BOUNEDJAR ADDA, Professor
- Email: a_bounedjar@yahoo.fr
- Phone: +213 25 20 90 72
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.